WHITEHAWK THERAPEUTICS, INC. Proceeds from Notes Payable
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Proceeds from Notes Payable of $120.00 thousand for the 67-month period ending 2013-06-30, per its 10-Q filed 2013-08-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2013-08-14
- 2013-06-30: Proceeds from Notes Payable 6 month $25.00K; Proceeds from Notes Payable 67 month $120.00K.
- 2012-06-30: Proceeds from Notes Payable 6 month $25.00K.
| Period end | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 67 month |
|---|---|---|
| 2013-06-30 | $25.00K 10-Q · filed 2013-08-14 | $120.00K 10-Q · filed 2013-08-14 |
| 2012-06-30 | $25.00K 10-Q · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |